Allergan's stock dropped 4% Thursday. Photo: Jean-Pierre Clatot / AFP via Getty Images
Allergan "does not intend to make an offer for Shire," the pharmaceutical giant said Thursday.
Driving the news: That's a quick reversal from earlier today, when Reuters reported Allergan was battling Takeda Pharmaceutical to take over Shire.